IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v194y2017icp51-59.html
   My bibliography  Save this article

Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application

Author

Listed:
  • Goldsmith, Laurie J.
  • Kolhatkar, Ashra
  • Popowich, Dominic
  • Holbrook, Anne M.
  • Morgan, Steven G.
  • Law, Michael R.

Abstract

Many patients report skipping doses, splitting pills, or not filling prescriptions due to out-of-pocket costs—a phenomenon known as cost-related non-adherence (CRNA). This study investigated CRNA from the patient's perspective, and, to our knowledge, is the first study to undertake a qualitative investigation of CRNA specifically. We report the results from 35 semi-structured interviews conducted in 2014-15 with adults in four Canadian cities across two provinces. We used framework analysis to develop a CRNA typology to characterize major factors in patients' CRNA decisions. Our typology identifies four major components: (1) the insurance reason driving the drug cost, (2) the individual's overall financial flexibility, (3) the burden of drug cost on the individual's budget, and (4) the importance of the drug from the individual's perspective. The first two components set the context for CRNA and the final two components are the drivers for the CRNA decision. We also found four major patterns in CRNA experiences: (1) CRNA in individuals with low financial flexibility occurred for all levels of drug importance and all but the lowest level of cost burden; (2) CRNA for high importance drugs only occurred when the drug cost had a high burden on an individual's budget; (3) CRNA in individuals with more financial flexibility primarily occurred in drugs with medium importance but high or very high cost burdens; and (4) CRNA for low importance drugs occurred at almost all levels of drug cost burden. Our study furthers the understanding of how numerous factors such as income, insurance, and individual preferences combine and interact to influence CRNA and suggests that policy interventions must be multi-faceted or encourage significant insurance redesign to reduce CRNA.

Suggested Citation

  • Goldsmith, Laurie J. & Kolhatkar, Ashra & Popowich, Dominic & Holbrook, Anne M. & Morgan, Steven G. & Law, Michael R., 2017. "Understanding the patient experience of cost-related non-adherence to prescription medications through typology development and application," Social Science & Medicine, Elsevier, vol. 194(C), pages 51-59.
    • Handle: RePEc:eee:socmed:v:194:y:2017:i:c:p:51-59
    DOI: 10.1016/j.socscimed.2017.10.007
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0277953617306123
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.socscimed.2017.10.007?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Doran, Evan & Robertson, Jane & Henry, David, 2005. "Moral hazard and prescription medicine use in Australia--the patient perspective," Social Science & Medicine, Elsevier, vol. 60(7), pages 1437-1443, April.
    2. Piette, John D. & Heisler, Michele & Horne, Robert & Caleb Alexander, G., 2006. "A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures," Social Science & Medicine, Elsevier, vol. 62(4), pages 846-857, February.
    3. Steve Morgan & Jamie R. Daw & Michael R. Law, 2013. "Rethinking Pharmacare in Canada," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 384, June.
    4. Stevenson, Fiona A. & Barry, Christine A. & Britten, Nicky & Barber, Nick & Bradley, Colin P., 2000. "Doctor-patient communication about drugs: the evidence for shared decision making," Social Science & Medicine, Elsevier, vol. 50(6), pages 829-840, March.
    5. Pound, Pandora & Britten, Nicky & Morgan, Myfanwy & Yardley, Lucy & Pope, Catherine & Daker-White, Gavin & Campbell, Rona, 2005. "Resisting medicines: a synthesis of qualitative studies of medicine taking," Social Science & Medicine, Elsevier, vol. 61(1), pages 133-155, July.
    6. Sarah-Jo Sinnott & Claire Buckley & David O′Riordan & Colin Bradley & Helen Whelton, 2013. "The Effect of Copayments for Prescriptions on Adherence to Prescription Medicines in Publicly Insured Populations; A Systematic Review and Meta-Analysis," PLOS ONE, Public Library of Science, vol. 8(5), pages 1-11, May.
    7. Wagner, Todd H. & Heisler, Michele & Piette, John D., 2008. "Prescription drug co-payments and cost-related medication underuse," Health Economics, Policy and Law, Cambridge University Press, vol. 3(1), pages 51-67, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rättö, Hanna & Kurko, Terhi & Martikainen, Jaana E. & Aaltonen, Katri, 2021. "The impact of a co-payment increase on the consumption of type 2 antidiabetics – A nationwide interrupted time series analysis," Health Policy, Elsevier, vol. 125(9), pages 1166-1172.
    2. Rachev, Boris & Uyei, Jennifer & Singh, Rajpal & Kowal, Stacey & Johnson, C. Erwin, 2021. "Stakeholder point of view on prescription drug affordability - a systematic literature review and content analysis," Health Policy, Elsevier, vol. 125(9), pages 1158-1165.
    3. Shikha Gupta & Mary Ann McColl & Sara J.T. Guilcher & Karen Smith, 2019. "Managing Medication Cost Burden: A Qualitative Study Exploring Experiences of People with Disabilities in Canada," IJERPH, MDPI, vol. 16(17), pages 1-17, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fraeyman, Jessica & Symons, Linda & De Loof, Hans & De Meyer, Guido R.Y. & Remmen, Roy & Beutels, Philippe & Van Hal, Guido, 2015. "Medicine price awareness in chronic patients in Belgium," Health Policy, Elsevier, vol. 119(2), pages 217-223.
    2. Noerreslet, Mikkel & Jemec, Gregor B.E. & Traulsen, Janine M., 2009. "Involuntary autonomy: Patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis," Social Science & Medicine, Elsevier, vol. 69(9), pages 1409-1415, November.
    3. Polak, Louisa & Green, Judith, 2020. "Rethinking decision-making in the context of preventive medication: How taking statins becomes “the right thing to do”," Social Science & Medicine, Elsevier, vol. 247(C).
    4. Malpass, Alice & Shaw, Alison & Sharp, Debbie & Walter, Fiona & Feder, Gene & Ridd, Matthew & Kessler, David, 2009. ""Medication career" or "Moral career"? The two sides of managing antidepressants: A meta-ethnography of patients' experience of antidepressants," Social Science & Medicine, Elsevier, vol. 68(1), pages 154-168, January.
    5. Daniel Schwanen, 2013. "Uneasy Birth: What Canadians Should Expect from a Canada-EU Trade Deal," e-briefs 163, C.D. Howe Institute.
    6. Allison Williams & Jac Kee Low & Elizabeth Manias & Kimberley Crawford, 2016. "The transplant team's support of kidney transplant recipients to take their prescribed medications: a collective responsibility," Journal of Clinical Nursing, John Wiley & Sons, vol. 25(15-16), pages 2251-2261, August.
    7. Rebecca J Bartlett Ellis & Janet L Welch, 2017. "Medication‐taking behaviours in chronic kidney disease with multiple chronic conditions: a meta‐ethnographic synthesis of qualitative studies," Journal of Clinical Nursing, John Wiley & Sons, vol. 26(5-6), pages 586-598, March.
    8. repec:wly:econjl:v::y:2017:i:605:p:f236-f265 is not listed on IDEAS
    9. Jyh-Jeng Wu & Yueh-Mei Chen & Paul C. Talley & Kuang-Ming Kuo, 2021. "Does Online Community Participation Contribute to Medication Adherence? An Empirical Study of Patients with Chronic Diseases," IJERPH, MDPI, vol. 18(10), pages 1-16, May.
    10. Ake Blomqvist & Colin Busby, 2015. "Rethinking Canada’s Unbalanced Mix of Public and Private Healthcare: Insights from Abroad," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 420, February.
    11. May, Carl & Rapley, Tim & Moreira, Tiago & Finch, Tracy & Heaven, Ben, 2006. "Technogovernance: Evidence, subjectivity, and the clinical encounter in primary care medicine," Social Science & Medicine, Elsevier, vol. 62(4), pages 1022-1030, February.
    12. Solomon, Josie & Knapp, Peter & Raynor, D.K. & Atkin, Karl, 2013. "Worlds apart? An exploration of prescribing and medicine-taking decisions by patients, GPs and local policy makers," Health Policy, Elsevier, vol. 112(3), pages 264-272.
    13. Loukas Balafoutas & Rudolf Kerschbamer & Matthias Sutter, 2017. "Second‐Degree Moral Hazard In A Real‐World Credence Goods Market," Economic Journal, Royal Economic Society, vol. 127(599), pages 1-18, February.
    14. Dew, Kevin & Norris, Pauline & Gabe, Jonathan & Chamberlain, Kerry & Hodgetts, Darrin, 2015. "Moral discourses and pharmaceuticalised governance in households," Social Science & Medicine, Elsevier, vol. 131(C), pages 272-279.
    15. Paraponaris, A. & Verger, P. & Desquins, B. & Villani, P. & Bouvenot, G. & Rochaix, L. & Gourheux, J. C. & Moatti, J. P. AU -, 2004. "Delivering generics without regulatory incentives?: Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names," Health Policy, Elsevier, vol. 70(1), pages 23-32, October.
    16. Stefan Stremersch & Vardit Landsman & Sriram Venkataraman, 2013. "The Relationship Between DTCA, Drug Requests, and Prescriptions: Uncovering Variation in Specialty and Space," Marketing Science, INFORMS, vol. 32(1), pages 89-110, June.
    17. Gabe, Jonathan & Williams, Simon J. & Coveney, Catherine M., 2017. "Prescription hypnotics in the news: A study of UK audiences," Social Science & Medicine, Elsevier, vol. 174(C), pages 43-52.
    18. Wang, Chao & Li, Qing & Sweetman, Arthur & Hurley, Jeremiah, 2015. "Mandatory universal drug plan, access to health care and health: Evidence from Canada," Journal of Health Economics, Elsevier, vol. 44(C), pages 80-96.
    19. O’Brady, Sean & Gagnon, Marc-André & Cassels, Alan, 2015. "Reforming private drug coverage in Canada: Inefficient drug benefit design and the barriers to change in unionized settings," Health Policy, Elsevier, vol. 119(2), pages 224-231.
    20. Armstrong, David, 2023. "The social life of risk probabilities in medicine," Social Science & Medicine, Elsevier, vol. 323(C).
    21. Webster, Michelle, 2017. "Similarities and differences in the meanings children and their parents attach to epilepsy medications," Social Science & Medicine, Elsevier, vol. 177(C), pages 190-197.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:194:y:2017:i:c:p:51-59. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.